APOE and amyloidosis: Apolipoprotein E ε4 (APOE4) is the largest genetic risk factor for development of sporadic AD [4] and has been shown to increase amyloid deposition in a dose-dependent manner, in the asymptomatic, the mild cognitive impairment and the dementia stages of AD [5–7].